RxDoctor Payments Data

Curtis Stokes, MD

Family Medicine · Walterboro, SCNPI 1396784369

Payments from drug & device makers

$672in general payments, 2019–2025

Across 28 payments — averaging $24.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$342
  • Johnson & Johnson$104
  • Cardiovascular Systems Inc.$94
  • Pfizer$48
  • Dexcom, Inc.$18
  • AstraZeneca$18
  • plus $48 from 4 others

What the payments were for

  • Food & beverage$671100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$672 in reported general payments places this provider in the 50th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$2,963
Medicare patients
67
Services billed
108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban134$116,753
JardianceEmpagliflozin96$80,888
RybelsusSemaglutide50$63,289
Trelegy ElliptaFluticasone/Umeclidin/Vilanter59$47,115
JanuviaSitagliptin Phosphate64$46,870
FarxigaDapagliflozin Propanediol65$42,238
LinzessLinaclotide67$41,706
OzempicSemaglutide40$39,716
Combivent RespimatIpratropium/Albuterol Sulfate47$35,793
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog40$22,035
XareltoRivaroxaban20$20,975
TrulicityDulaglutide20$19,265
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$19,128
Tresiba Flextouch U-200Insulin Degludec18$14,581
MyrbetriqMirabegron20$13,537

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$48$116,753134 claims
Novo NordiskRybelsus, Ozempic$342$103,00590 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$18$73,623127 claims
Johnson & JohnsonXarelto$104$20,97520 claims
NovartisEntresto$17$13,22418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Walterboro

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →